Pictet Asset Management (Switzerland)’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $179M | Buy |
2,063,810
+9,288
| +0.5% | +$805K | 0.21% | 124 |
|
|
2023
Q1 | $200M | Buy |
2,054,522
+576,001
| +39% | +$56M | 0.25% | 120 |
|
|
2022
Q4 | $153M | Buy |
1,478,521
+710,154
| +92% | +$73.5M | 0.22% | 139 |
|
|
2022
Q3 | $65.1M | Buy |
768,367
+276,664
| +56% | +$23.5M | 0.1% | 235 |
|
|
2022
Q2 | $40.7M | Buy |
491,703
+12,923
| +3% | +$1.07M | 0.06% | 318 |
|
|
2022
Q1 | $36.9M | Sell |
478,780
-7,994
| -2% | -$616K | 0.04% | 371 |
|
|
2021
Q4 | $43M | Sell |
486,774
-268,054
| -36% | -$23.7M | 0.04% | 367 |
|
|
2021
Q3 | $58.3M | Buy |
+754,828
| New | +$58.3M | 0.06% | 306 |
|